LIDOCAINE AND PRILOCAINE

LIDOCAINE AND PRILOCAINE was reported 1450 times

LIDOCAINE AND PRILOCAINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPUTERISED TOMOGRAM INTESTINE 1 0.3333
1 MYOCARDITIS TOXOPLASMAL 2 0.1176
2 HAEMOPHILUS SEPSIS 6 0.1053
3 BONE MARROW PLASMACYTE COUNT INCREASED 1 0.0833
4 CSF RED BLOOD CELL COUNT POSITIVE 1 0.0286
5 ALLERGY TO IMMUNOGLOBULIN THERAPY 2 0.0183
6 ELECTROENCEPHALOGRAM 1 0.0179
7 ANAL CANDIDIASIS 1 0.0172
8 CATHETER SITE SCAR 1 0.0167
9 CIRCUMORAL SWELLING 2 0.0156
10 BARTONELLOSIS 1 0.0152
11 ABDOMINAL MIGRAINE 1 0.0147
12 CHEMICAL BURN OF GASTROINTESTINAL TRACT 2 0.0146
13 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 1 0.0139
14 EAR, NOSE AND THROAT INFECTION 1 0.0122
15 CATHETER SITE EROSION 1 0.0110
16 BACILLUS TEST POSITIVE 1 0.0101
17 CEREBROSPINAL FLUID RETENTION 1 0.0085
18 ACHROMOBACTER INFECTION 1 0.0083
19 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
20 GINGIVAL EROSION 2 0.0078
21 DEVICE WIRELESS COMMUNICATION ISSUE 2 0.0077
22 HYPERLIPASAEMIA 4 0.0076
23 ALBUMIN GLOBULIN RATIO INCREASED 1 0.0073
24 MONOCLONAL IMMUNOGLOBULIN INCREASED 2 0.0070
25 EAR INFLAMMATION 2 0.0069
26 MESENTERIC PANNICULITIS 2 0.0067
27 CATHETER SITE MASS 1 0.0066
28 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 1 0.0065
29 DRUG TITRATION 1 0.0064
30 THERAPEUTIC EMBOLISATION 2 0.0064
31 GALLBLADDER HYPOFUNCTION 1 0.0058
32 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
33 METHAEMOGLOBINAEMIA 13 0.0056
34 INFUSION SITE IRRITATION 6 0.0047
35 EXPOSURE TO FUNGUS 1 0.0047
36 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
37 CATHETER SITE SWELLING 4 0.0043
38 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
39 ELECTROCARDIOGRAM P WAVE ABNORMAL 1 0.0041
40 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 1 0.0040
41 ADENOTONSILLECTOMY 1 0.0040
42 SPLENIC VEIN THROMBOSIS 2 0.0039
43 GASTROINTESTINAL FUNGAL INFECTION 2 0.0039
44 HYPERTENSIVE URGENCY 2 0.0036
45 DENTAL PLAQUE 1 0.0036
46 INFECTED BITE 3 0.0035
47 CARBON DIOXIDE DECREASED 4 0.0035
48 DEVICE MAINTENANCE ISSUE 2 0.0034
49 EAR TUBE INSERTION 1 0.0034
50 CREATININE URINE INCREASED 1 0.0033
51 ASTIGMATISM 5 0.0033
52 DEFIANT BEHAVIOUR 1 0.0032
53 CATHETER SITE PAIN 8 0.0031
54 ADMINISTRATION SITE SWELLING 1 0.0031
55 CATHETER SITE BRUISE 1 0.0030
56 INFUSION SITE DISCOMFORT 3 0.0029
57 OPHTHALMIC MIGRAINE 2 0.0029
58 ANION GAP DECREASED 1 0.0029
59 INFUSION SITE PRURITUS 9 0.0028
60 FLUID IMBALANCE 2 0.0028
61 COMPLICATIONS OF TRANSPLANTED LIVER 1 0.0028
62 CYTOMEGALOVIRUS OESOPHAGITIS 1 0.0027
63 CAUDA EQUINA SYNDROME 2 0.0026
64 ALLERGY TO CHEMICALS 3 0.0024
65 CORNEAL DYSTROPHY 1 0.0024
66 ALVEOLAR OSTEITIS 1 0.0024
67 CRANIOFACIAL FRACTURE 2 0.0023
68 TRANSFUSION REACTION 2 0.0023
69 INFUSION SITE DISCHARGE 4 0.0023
70 INFUSION SITE DISCOLOURATION 2 0.0023
71 BLOOD ALBUMIN INCREASED 2 0.0022
72 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
73 FIBROADENOMA OF BREAST 1 0.0022
74 ALLERGY TO ARTHROPOD STING 1 0.0022
75 INFUSION SITE RASH 3 0.0022
76 EHLERS-DANLOS SYNDROME 1 0.0022
77 CEREBRAL TOXOPLASMOSIS 2 0.0021
78 WRIST SURGERY 2 0.0021
79 INFUSION SITE NODULE 2 0.0021
80 BLADDER MASS 1 0.0020
81 INFUSION SITE REACTION 6 0.0020
82 AUTOIMMUNE PANCREATITIS 1 0.0020
83 PRODUCT CLOSURE REMOVAL DIFFICULT 2 0.0020
84 STEROID WITHDRAWAL SYNDROME 2 0.0020
85 CAROTID ARTERIOSCLEROSIS 2 0.0019
86 WAIST CIRCUMFERENCE INCREASED 2 0.0019
87 DEVICE USE CONFUSION 1 0.0019
88 BONE CANCER METASTATIC 1 0.0019
89 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 2 0.0019
90 RADIATION INJURY 2 0.0019
91 CATHETER SITE ERYTHEMA 4 0.0019
92 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
93 TOXOPLASMOSIS 2 0.0019
94 EPHELIDES 1 0.0019
95 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
96 INFUSION SITE MASS 2 0.0018
97 INFUSION SITE HAEMORRHAGE 6 0.0018
98 INFUSION SITE PAIN 23 0.0018
99 INFUSION SITE SWELLING 11 0.0017
100 DOSE CALCULATION ERROR 1 0.0017
101 INFUSION SITE ERYTHEMA 14 0.0017
102 CENTRAL VENOUS CATHETERISATION 5 0.0017
103 CEREBRAL ARTERY EMBOLISM 2 0.0016
104 POST-ACUTE COVID-19 SYNDROME 2 0.0016
105 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
106 BLOOD IRON INCREASED 3 0.0016
107 RADIOTHERAPY 3 0.0016
108 LIP INJURY 2 0.0015
109 RESPIRATORY ACIDOSIS 6 0.0015
110 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
111 CORNEAL ABRASION 2 0.0015
112 CEREBRAL CYST 1 0.0015
113 FOREARM FRACTURE 1 0.0014
114 INFUSION SITE BRUISING 3 0.0014
115 DENTAL RESTORATION FAILURE 1 0.0014
116 NOROVIRUS INFECTION 2 0.0014
117 KNEE DEFORMITY 2 0.0013
118 CARCINOID TUMOUR 1 0.0013
119 CARDIAC INFECTION 1 0.0013
120 CATHETER SITE INFECTION 5 0.0013
121 PNEUMONIA PSEUDOMONAL 2 0.0013
122 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
123 MEAN CELL VOLUME DECREASED 2 0.0013
124 INFUSION SITE INFECTION 3 0.0013
125 INFUSION SITE EXTRAVASATION 8 0.0013
126 RHINOVIRUS INFECTION 5 0.0013
127 CORNEAL TRANSPLANT 1 0.0013
128 CROUP INFECTIOUS 1 0.0013
129 BREAST CALCIFICATIONS 1 0.0013
130 WEIGHT ABNORMAL 3 0.0012
131 DERMATITIS CONTACT 14 0.0012
132 DEVICE INFUSION ISSUE 3 0.0012
133 CARDIAC STRESS TEST ABNORMAL 1 0.0012
134 FUNGAL SEPSIS 1 0.0012
135 MITRAL VALVE PROLAPSE 2 0.0012
136 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
137 BLOOD CHLORIDE INCREASED 2 0.0012
138 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
139 SPINAL CORD INJURY 2 0.0011
140 OTORRHOEA 2 0.0011
141 BURNS SECOND DEGREE 2 0.0011
142 INSURANCE ISSUE 17 0.0011
143 NASAL OEDEMA 2 0.0011
144 DEVICE ALARM ISSUE 2 0.0011
145 ESSENTIAL HYPERTENSION 2 0.0011
146 CATHETER PLACEMENT 2 0.0011
147 LYMPH NODE PAIN 2 0.0011
148 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 1 0.0011
149 ADRENAL DISORDER 2 0.0010
150 EMPYEMA 2 0.0010
151 MYELOFIBROSIS 3 0.0010
152 BLADDER DYSFUNCTION 1 0.0010
153 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
154 PNEUMONIA VIRAL 3 0.0009
155 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
156 EAR INFECTION 25 0.0009
157 BLADDER DILATATION 1 0.0009
158 URINE OUTPUT DECREASED 8 0.0009
159 BACTERIAL TEST POSITIVE 2 0.0009
160 CATHETER SITE DISCHARGE 1 0.0009
161 BLOODY DISCHARGE 1 0.0009
162 POOR VENOUS ACCESS 9 0.0009
163 PRODUCT DISTRIBUTION ISSUE 8 0.0009
164 HYPERTRIGLYCERIDAEMIA 5 0.0009
165 FEBRILE INFECTION 1 0.0008
166 INGROWING NAIL 2 0.0008
167 URINARY HESITATION 2 0.0008
168 BILE DUCT STENOSIS 1 0.0008
169 CHRONIC RESPIRATORY FAILURE 1 0.0008
170 PRODUCT PACKAGING CONFUSION 2 0.0008
171 HAEMATOLOGICAL INFECTION 2 0.0008
172 BREATH SOUNDS ABNORMAL 4 0.0008
173 CATHETER SITE HAEMORRHAGE 2 0.0008
174 HYPERPARATHYROIDISM SECONDARY 2 0.0008
175 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
176 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
177 PARANASAL SINUS DISCOMFORT 3 0.0008
178 BAND SENSATION 1 0.0008
179 GASTROENTERITIS VIRAL 14 0.0008
180 BILIARY OBSTRUCTION 1 0.0008
181 ORAL INFECTION 3 0.0008
182 WEIGHT FLUCTUATION 8 0.0008
183 ACROCHORDON 1 0.0008
184 OBSTRUCTION 3 0.0008
185 WHITE BLOOD CELL DISORDER 2 0.0007
186 FOOD POISONING 4 0.0007
187 BODY MASS INDEX INCREASED 1 0.0007
188 PHARYNGITIS STREPTOCOCCAL 8 0.0007
189 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
190 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
191 SEASONAL ALLERGY 10 0.0007
192 CATAPLEXY 1 0.0007
193 OXYGEN SATURATION ABNORMAL 2 0.0007
194 BLOOD ELECTROLYTES DECREASED 1 0.0007
195 PANCREATIC CARCINOMA METASTATIC 2 0.0007
196 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
197 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
198 DYSPNOEA AT REST 2 0.0007
199 TONGUE DISCOLOURATION 3 0.0007
200 PULMONARY PAIN 2 0.0007
201 DEVICE POWER SOURCE ISSUE 2 0.0007
202 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
203 TOOTH INFECTION 9 0.0007
204 BLOOD PARATHYROID HORMONE DECREASED 1 0.0007
205 COLON CANCER 10 0.0007
206 ATYPICAL PNEUMONIA 2 0.0007
207 METABOLIC ENCEPHALOPATHY 2 0.0007
208 INGUINAL HERNIA 4 0.0007
209 BLOOD PRESSURE IMMEASURABLE 1 0.0007
210 HEREDITARY ANGIOEDEMA 7 0.0007
211 RECTAL CANCER 2 0.0007
212 BRONCHIAL DISORDER 1 0.0006
213 MULTIPLE ALLERGIES 5 0.0006
214 SKIN ABRASION 3 0.0006
215 HEPATIC CYTOLYSIS 8 0.0006
216 CYSTITIS INTERSTITIAL 1 0.0006
217 AORTIC VALVE DISEASE 1 0.0006
218 POSTURE ABNORMAL 2 0.0006
219 INJECTION SITE INFECTION 2 0.0006
220 HYPERVOLAEMIA 3 0.0006
221 APPLICATION SITE SWELLING 3 0.0006
222 TONGUE ULCERATION 2 0.0006
223 EROSIVE OESOPHAGITIS 1 0.0006
224 EXPOSURE TO SARS-COV-2 1 0.0006
225 CARBOHYDRATE ANTIGEN 125 INCREASED 2 0.0006
226 ACUTE SINUSITIS 1 0.0006
227 PARTIAL SEIZURES 3 0.0006
228 BREAST CYST 1 0.0006
229 OESOPHAGITIS 6 0.0005
230 CONTRAST MEDIA ALLERGY 1 0.0005
231 HYPERKERATOSIS 3 0.0005
232 BODY TEMPERATURE ABNORMAL 1 0.0005
233 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
234 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
235 MALNUTRITION 6 0.0005
236 SKIN INFECTION 6 0.0005
237 BLADDER SPASM 1 0.0005
238 ADENOCARCINOMA OF COLON 1 0.0005
239 PROTEIN TOTAL DECREASED 2 0.0005
240 BLOOD BICARBONATE DECREASED 1 0.0005
241 ARTERIAL DISORDER 1 0.0005
242 ACUTE RESPIRATORY FAILURE 10 0.0005
243 SKIN WARM 3 0.0005
244 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
245 DYSPNOEA EXERTIONAL 19 0.0005
246 BLOOD ALBUMIN DECREASED 4 0.0005
247 OESOPHAGEAL CANDIDIASIS 2 0.0005
248 ANORECTAL DISORDER 1 0.0005
249 MUSCLE HAEMORRHAGE 2 0.0005
250 DEVICE RELATED SEPSIS 1 0.0005
251 CARDIAC DISCOMFORT 1 0.0005
252 VITAMIN B12 DEFICIENCY 2 0.0005
253 DERMATITIS ACNEIFORM 3 0.0005
254 SPINAL FUSION SURGERY 2 0.0005
255 PERIPHERAL ISCHAEMIA 2 0.0005
256 CHEST INJURY 1 0.0005
257 DEVICE CONNECTION ISSUE 1 0.0005
258 FULL BLOOD COUNT ABNORMAL 5 0.0005
259 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
260 ENTERITIS 3 0.0005
261 PURULENT DISCHARGE 2 0.0005
262 BLOOD TESTOSTERONE INCREASED 1 0.0005
263 EXOPHTHALMOS 1 0.0005
264 ABSCESS INTESTINAL 1 0.0005
265 APPLICATION SITE VESICLES 3 0.0005
266 RESPIRATORY TRACT INFECTION 12 0.0005
267 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
268 SINUSITIS 47 0.0005
269 HYPOGAMMAGLOBULINAEMIA 3 0.0005
270 ONYCHOMYCOSIS 2 0.0005
271 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
272 PARONYCHIA 2 0.0005
273 DEVICE RELATED INFECTION 7 0.0005
274 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
275 COLONOSCOPY 1 0.0005
276 GINGIVAL SWELLING 2 0.0005
277 LIGAMENT RUPTURE 2 0.0005
278 RHINITIS ALLERGIC 2 0.0004
279 CALCINOSIS 1 0.0004
280 GASTROINTESTINAL INFECTION 4 0.0004
281 PNEUMOTHORAX 7 0.0004
282 BODY TEMPERATURE INCREASED 9 0.0004
283 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
284 AGEUSIA 11 0.0004
285 VASCULAR DEVICE INFECTION 2 0.0004
286 END STAGE RENAL DISEASE 8 0.0004
287 UROSEPSIS 4 0.0004
288 BILIRUBIN CONJUGATED INCREASED 1 0.0004
289 DEVICE OCCLUSION 6 0.0004
290 INTENTIONAL DOSE OMISSION 12 0.0004
291 VIRAL INFECTION 14 0.0004
292 DERMAL CYST 1 0.0004
293 SMALL INTESTINAL OBSTRUCTION 5 0.0004
294 FOOT OPERATION 2 0.0004
295 BLOOD COUNT ABNORMAL 6 0.0004
296 APPENDICITIS PERFORATED 1 0.0004
297 CANCER PAIN 1 0.0004
298 GOUT 7 0.0004
299 AORTIC ARTERIOSCLEROSIS 1 0.0004
300 TRISMUS 2 0.0004
301 HYPOALBUMINAEMIA 3 0.0004
302 ACTINIC KERATOSIS 1 0.0004
303 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
304 SENSITIVITY TO WEATHER CHANGE 2 0.0004
305 FURUNCLE 3 0.0004
306 RESPIRATORY TRACT CONGESTION 6 0.0004
307 ANIMAL BITE 1 0.0004
308 BLOOD POTASSIUM ABNORMAL 1 0.0004
309 BLOOD SODIUM INCREASED 1 0.0004
310 HIP SURGERY 2 0.0004
311 EAR CONGESTION 1 0.0004
312 POST PROCEDURAL INFECTION 3 0.0004
313 GASTRIC PERFORATION 1 0.0004
314 CLONUS 1 0.0004
315 BRONCHITIS 27 0.0004
316 POST PROCEDURAL COMPLICATION 7 0.0004
317 HAIR DISORDER 3 0.0004
318 TOOTH FRACTURE 4 0.0004
319 DRUG SCREEN FALSE POSITIVE 1 0.0004
320 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
321 EAR PAIN 7 0.0004
322 PRODUCT LEAKAGE 2 0.0004
323 SKIN TOXICITY 2 0.0004
324 FIBULA FRACTURE 1 0.0003
325 MUSCLE STRAIN 3 0.0003
326 METASTASES TO LUNG 4 0.0003
327 SKIN SWELLING 3 0.0003
328 ADENOVIRUS INFECTION 1 0.0003
329 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
330 CARDIOTOXICITY 3 0.0003
331 CREPITATIONS 1 0.0003
332 ANAL INCONTINENCE 3 0.0003
333 ACNE CYSTIC 1 0.0003
334 CRANIOCEREBRAL INJURY 1 0.0003
335 EMBOLISM VENOUS 1 0.0003
336 EYE INJURY 1 0.0003
337 INCREASED TENDENCY TO BRUISE 3 0.0003
338 DUODENITIS 1 0.0003
339 SPINAL OPERATION 4 0.0003
340 SCOLIOSIS 2 0.0003
341 CHOLANGITIS 2 0.0003
342 FAMILY STRESS 1 0.0003
343 PRE-EXISTING CONDITION IMPROVED 2 0.0003
344 ILLNESS 33 0.0003
345 SECRETION DISCHARGE 4 0.0003
346 CYANOSIS 5 0.0003
347 LEUKAEMIA 3 0.0003
348 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
349 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
350 PROCTALGIA 2 0.0003
351 DYSPHONIA 18 0.0003
352 POLYP 2 0.0003
353 BLADDER DISORDER 3 0.0003
354 INABILITY TO AFFORD MEDICATION 3 0.0003
355 SKIN MASS 2 0.0003
356 BLOOD POTASSIUM DECREASED 9 0.0003
357 TERMINAL STATE 2 0.0003
358 SINUS CONGESTION 4 0.0003
359 WRONG PRODUCT ADMINISTERED 2 0.0003
360 PRODUCTIVE COUGH 14 0.0003
361 NASOPHARYNGITIS 54 0.0003
362 EUPHORIC MOOD 3 0.0003
363 TEMPERATURE INTOLERANCE 3 0.0003
364 JOINT EFFUSION 2 0.0003
365 CERVICAL VERTEBRAL FRACTURE 1 0.0003
366 LARGE INTESTINE PERFORATION 2 0.0003
367 NEOPLASM PROGRESSION 10 0.0003
368 PETECHIAE 3 0.0003
369 HYPOMAGNESAEMIA 4 0.0003
370 NEUROTOXICITY 5 0.0003
371 HYPERKALAEMIA 10 0.0003
372 METASTASES TO LIVER 5 0.0003
373 HYPOXIA 10 0.0003
374 INCONTINENCE 3 0.0003
375 PLASMA CELL MYELOMA 11 0.0003
376 FIBRIN D DIMER INCREASED 1 0.0003
377 RED BLOOD CELL COUNT DECREASED 8 0.0003
378 BONE LESION 1 0.0003
379 RESTLESS LEGS SYNDROME 5 0.0003
380 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
381 INTENTIONAL UNDERDOSE 2 0.0003
382 BLOOD PHOSPHORUS DECREASED 1 0.0003
383 DENTAL CARIES 3 0.0003
384 HYPOPHOSPHATAEMIA 2 0.0003
385 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
386 ARTHROPOD BITE 2 0.0003
387 INFLUENZA 30 0.0003
388 ORAL PAIN 6 0.0003
389 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
390 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
391 BLOOD SODIUM DECREASED 5 0.0003
392 AUTOIMMUNE THYROIDITIS 1 0.0003
393 COLITIS 10 0.0003
394 DEVICE FAILURE 4 0.0003
395 PLATELET COUNT DECREASED 28 0.0003
396 NEOPLASM 3 0.0003
397 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 47 0.0003
398 FOOD ALLERGY 2 0.0003
399 MADAROSIS 3 0.0003
400 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
401 THERAPY PARTIAL RESPONDER 4 0.0003
402 FEBRILE NEUTROPENIA 17 0.0003
403 EPIGASTRIC DISCOMFORT 1 0.0003
404 NASAL CONGESTION 15 0.0003
405 KIDNEY INFECTION 5 0.0003
406 LYMPHADENOPATHY 9 0.0003
407 COVID-19 PNEUMONIA 3 0.0003
408 SINUS DISORDER 5 0.0003
409 RENAL CYST 2 0.0003
410 GINGIVAL PAIN 2 0.0003
411 AZOTAEMIA 1 0.0003
412 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
413 FULL BLOOD COUNT DECREASED 5 0.0002
414 ENURESIS 1 0.0002
415 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
416 NOCTURIA 3 0.0002
417 PRODUCT DOSE OMISSION ISSUE 72 0.0002
418 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
419 PHARYNGITIS 3 0.0002
420 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
421 INFUSION RELATED REACTION 16 0.0002
422 HAIR COLOUR CHANGES 3 0.0002
423 EMBOLISM 2 0.0002
424 NEPHROLITHIASIS 11 0.0002
425 BLOOD UREA INCREASED 4 0.0002
426 ASCITES 7 0.0002
427 LABORATORY TEST ABNORMAL 7 0.0002
428 INADEQUATE ANALGESIA 2 0.0002
429 RESPIRATORY DISORDER 7 0.0002
430 COVID-19 41 0.0002
431 IRRITABLE BOWEL SYNDROME 5 0.0002
432 BLOOD MAGNESIUM DECREASED 2 0.0002
433 PSYCHOLOGICAL TRAUMA 2 0.0002
434 PLEURAL EFFUSION 14 0.0002
435 BONE CANCER 1 0.0002
436 NAIL DISORDER 2 0.0002
437 ORAL CANDIDIASIS 3 0.0002
438 GROIN PAIN 2 0.0002
439 LYMPHOCYTE COUNT DECREASED 4 0.0002
440 BLOOD CREATINE INCREASED 1 0.0002
441 COUGH 63 0.0002
442 HAIR TEXTURE ABNORMAL 3 0.0002
443 HAEMARTHROSIS 2 0.0002
444 THERAPY NON-RESPONDER 10 0.0002
445 BLOOD BILIRUBIN INCREASED 6 0.0002
446 NEUROPATHY PERIPHERAL 21 0.0002
447 DECREASED APPETITE 51 0.0002
448 PNEUMONIA BACTERIAL 2 0.0002
449 NERVE COMPRESSION 2 0.0002
450 IRON DEFICIENCY ANAEMIA 2 0.0002
451 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
452 NECK PAIN 12 0.0002
453 THINKING ABNORMAL 4 0.0002
454 STOMATITIS 13 0.0002
455 HEPATIC ENCEPHALOPATHY 2 0.0002
456 INFECTION 31 0.0002
457 FOOT FRACTURE 4 0.0002
458 PYREXIA 73 0.0002
459 LIP SWELLING 7 0.0002
460 FUNGAL INFECTION 7 0.0002
461 RECALLED PRODUCT ADMINISTERED 2 0.0002
462 PARALYSIS 3 0.0002
463 IMPAIRED QUALITY OF LIFE 3 0.0002
464 ATELECTASIS 2 0.0002
465 LOCALISED INFECTION 5 0.0002
466 LIVER FUNCTION TEST ABNORMAL 6 0.0002
467 DIZZINESS POSTURAL 2 0.0002
468 FATIGUE 160 0.0002
469 PHARYNGEAL SWELLING 2 0.0002
470 THERAPY CHANGE 2 0.0002
471 KNEE OPERATION 2 0.0002
472 BLOOD PRESSURE INCREASED 31 0.0002
473 HOSPICE CARE 2 0.0002
474 EXPIRED DRUG ADMINISTERED 1 0.0002
475 DIABETIC NEUROPATHY 1 0.0002
476 HAEMATOCRIT DECREASED 4 0.0002
477 PULMONARY MASS 3 0.0002
478 BLOOD PRESSURE ABNORMAL 4 0.0002
479 ANEURYSM 1 0.0002
480 PNEUMONIA 65 0.0002
481 RASH MACULAR 7 0.0002
482 PNEUMONIA ASPIRATION 5 0.0002
483 CYTOKINE RELEASE SYNDROME 4 0.0002
484 URINARY TRACT INFECTION 34 0.0002
485 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
486 HYPOAESTHESIA ORAL 3 0.0002
487 PERITONITIS BACTERIAL 2 0.0002
488 TASTE DISORDER 4 0.0002
489 WEIGHT DECREASED 55 0.0002
490 THROMBOCYTOPENIA 22 0.0002
491 SLUGGISHNESS 2 0.0002
492 HIP ARTHROPLASTY 3 0.0002
493 RIB FRACTURE 4 0.0002
494 ANAPHYLACTIC SHOCK 5 0.0002
495 FAILURE TO THRIVE 1 0.0002
496 ACUTE MYELOID LEUKAEMIA 3 0.0002
497 EYE DISCHARGE 2 0.0002
498 BRAIN FOG 3 0.0002
499 GASTRITIS 5 0.0002
500 SYNCOPE 19 0.0002
501 RENAL PAIN 2 0.0002
502 ULCER 3 0.0002
503 COMPRESSION FRACTURE 1 0.0002
504 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
505 BACK DISORDER 3 0.0002
506 PALLOR 5 0.0002
507 OROPHARYNGEAL PAIN 17 0.0002
508 PULMONARY THROMBOSIS 2 0.0002
509 MOOD ALTERED 5 0.0002
510 ASTHENOPIA 1 0.0002
511 AUTISM SPECTRUM DISORDER 1 0.0002
512 VOMITING 85 0.0002
513 FOOT DEFORMITY 2 0.0002
514 FEELING COLD 5 0.0002
515 HAEMOPTYSIS 5 0.0002
516 WOUND 5 0.0002
517 GASTROINTESTINAL DISORDER 16 0.0002
518 CHROMATURIA 4 0.0002
519 EYE INFECTION 2 0.0002
520 FLUID RETENTION 9 0.0002
521 CONTUSION 17 0.0002
522 PAIN IN JAW 5 0.0002
523 MYOCARDIAL ISCHAEMIA 2 0.0002
524 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
525 MICTURITION URGENCY 2 0.0002
526 CHOLECYSTECTOMY 2 0.0002
527 INTERNAL HAEMORRHAGE 2 0.0002
528 EPISTAXIS 13 0.0002
529 EXERCISE TOLERANCE DECREASED 1 0.0002
530 BLOOD URIC ACID INCREASED 1 0.0002
531 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
532 DEHYDRATION 23 0.0002
533 NEUTROPHIL COUNT DECREASED 7 0.0002
534 BURNING SENSATION 12 0.0002
535 SPLENOMEGALY 2 0.0002
536 DIARRHOEA 110 0.0002
537 COLD SWEAT 3 0.0002
538 RHINORRHOEA 11 0.0002
539 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
540 WHEEZING 10 0.0002
541 BLOOD IRON DECREASED 2 0.0002
542 DIABETIC KETOACIDOSIS 4 0.0002
543 LEUKOCYTOSIS 3 0.0002
544 NAUSEA 131 0.0002
545 PANIC ATTACK 6 0.0002
546 RESPIRATORY DEPRESSION 2 0.0002
547 MUSCLE SPASTICITY 2 0.0002
548 INJECTION SITE EXTRAVASATION 2 0.0002
549 HYPERCALCAEMIA 2 0.0002
550 ABNORMAL WEIGHT GAIN 2 0.0002
551 GENERALISED OEDEMA 2 0.0002
552 PANCYTOPENIA 9 0.0002
553 DEVICE DISLOCATION 7 0.0002
554 BACTERIAL INFECTION 3 0.0002
555 TOOTH EXTRACTION 2 0.0002
556 MIDDLE INSOMNIA 3 0.0002
557 CONSTIPATION 35 0.0002
558 OXYGEN SATURATION DECREASED 9 0.0002
559 SWOLLEN TONGUE 5 0.0002
560 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
561 HEAD INJURY 5 0.0002
562 PROTEINURIA 3 0.0002
563 HERPES ZOSTER 9 0.0002
564 LETHARGY 9 0.0002
565 CHEST DISCOMFORT 16 0.0002
566 SEIZURE 18 0.0002
567 NIGHT SWEATS 5 0.0002
568 ERUCTATION 3 0.0002
569 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
570 BONE PAIN 9 0.0002
571 BLOOD CREATININE INCREASED 10 0.0002
572 HYPOKALAEMIA 7 0.0002
573 SARS-COV-2 TEST POSITIVE 2 0.0002
574 CORONAVIRUS INFECTION 1 0.0002
575 PRESCRIBED UNDERDOSE 3 0.0002
576 GAIT INABILITY 5 0.0001
577 BREAST MASS 1 0.0001
578 BRONCHIECTASIS 1 0.0001
579 OEDEMA PERIPHERAL 18 0.0001
580 INJURY ASSOCIATED WITH DEVICE 3 0.0001
581 LIMB INJURY 4 0.0001
582 TACHYPNOEA 2 0.0001
583 NEUTROPENIA 20 0.0001
584 PNEUMONITIS 4 0.0001
585 ANAEMIA 28 0.0001
586 FEELING HOT 9 0.0001
587 MIGRAINE 14 0.0001
588 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
589 PROCEDURAL PAIN 4 0.0001
590 ORAL DISCOMFORT 2 0.0001
591 FORMICATION 1 0.0001
592 DISEASE PROGRESSION 17 0.0001
593 HUNGER 2 0.0001
594 EXTRASYSTOLES 1 0.0001
595 LUNG DISORDER 7 0.0001
596 CARPAL TUNNEL SYNDROME 2 0.0001
597 BLOOD TEST ABNORMAL 2 0.0001
598 APPLICATION SITE REACTION 1 0.0001
599 HYPONATRAEMIA 8 0.0001
600 FLATULENCE 8 0.0001
601 DIALYSIS 2 0.0001
602 FEAR OF INJECTION 1 0.0001
603 CARDIOGENIC SHOCK 2 0.0001
604 CELLULITIS 7 0.0001
605 DERMATITIS BULLOUS 1 0.0001
606 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
607 SEPTIC SHOCK 6 0.0001
608 SURGERY 8 0.0001
609 HAEMOGLOBIN DECREASED 14 0.0001
610 DIZZINESS 68 0.0001
611 DRY MOUTH 11 0.0001
612 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
613 TACHYCARDIA 12 0.0001
614 IMMUNODEFICIENCY 2 0.0001
615 SNEEZING 3 0.0001
616 THROAT IRRITATION 6 0.0001
617 PRODUCT USE ISSUE 25 0.0001
618 HEART RATE IRREGULAR 3 0.0001
619 ASTHMA 15 0.0001
620 PANCREATITIS 7 0.0001
621 ECONOMIC PROBLEM 2 0.0001
622 PRODUCT AVAILABILITY ISSUE 3 0.0001
623 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
624 DYSPNOEA 74 0.0001
625 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
626 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
627 MUSCLE TWITCHING 3 0.0001
628 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
629 PERICARDIAL EFFUSION 3 0.0001
630 THYROID DISORDER 2 0.0001
631 WEIGHT INCREASED 29 0.0001
632 LIMB DISCOMFORT 4 0.0001
633 ANKLE FRACTURE 2 0.0001
634 FEMUR FRACTURE 4 0.0001
635 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
636 LUNG INFECTION 2 0.0001
637 EJECTION FRACTION DECREASED 2 0.0001
638 PALPITATIONS 15 0.0001
639 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
640 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
641 PRODUCT USE COMPLAINT 2 0.0001
642 SICKLE CELL ANAEMIA WITH CRISIS 2 0.0001
643 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
644 THERAPY INTERRUPTED 9 0.0001
645 CYSTITIS 4 0.0001
646 SEPSIS 14 0.0001
647 BLOOD PRESSURE FLUCTUATION 3 0.0001
648 HYPOTENSION 25 0.0001
649 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
650 FRUSTRATION TOLERANCE DECREASED 1 0.0001
651 HYPOGLYCAEMIA 6 0.0001
652 MUSCLE TIGHTNESS 2 0.0001
653 BLOOD POTASSIUM INCREASED 2 0.0001
654 LIVER INJURY 3 0.0001
655 PAIN IN EXTREMITY 36 0.0001
656 DYSPEPSIA 12 0.0001
657 METASTASES TO BONE 2 0.0001
658 ESCHERICHIA INFECTION 1 0.0001
659 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
660 BACK PAIN 28 0.0001
661 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
662 BLOOD PRESSURE DECREASED 8 0.0001
663 ABDOMINAL PAIN 28 0.0001
664 EXPIRED PRODUCT ADMINISTERED 4 0.0001
665 ROAD TRAFFIC ACCIDENT 5 0.0001
666 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
667 CHRONIC KIDNEY DISEASE 9 0.0001
668 CANDIDA INFECTION 2 0.0001
669 FLUSHING 12 0.0001
670 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
671 FACIAL PARALYSIS 1 0.0001
672 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
673 THERAPY CESSATION 6 0.0001
674 SCAR 2 0.0001
675 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
676 MUSCULOSKELETAL DISCOMFORT 2 0.0001
677 ARTHRALGIA 48 0.0001
678 ABDOMINAL DISTENSION 12 0.0001
679 PRURITUS 44 0.0001
680 APPLICATION SITE ERYTHEMA 3 0.0001
681 JOINT STIFFNESS 3 0.0001
682 ANHEDONIA 3 0.0001
683 URTICARIA 19 0.0001
684 CHEST PAIN 21 0.0001
685 HYPERSENSITIVITY 21 0.0001
686 OFF LABEL USE 99 0.0001
687 HEAD DISCOMFORT 2 0.0001
688 DRUG ERUPTION 2 0.0001
689 FEELING ABNORMAL 27 0.0001
690 BREAST CANCER FEMALE 3 0.0001
691 ALOPECIA 22 0.0001
692 THIRST 2 0.0001
693 ASTHENIA 42 0.0001
694 PAIN OF SKIN 3 0.0001
695 FALL 37 0.0001
696 ACUTE KIDNEY INJURY 17 0.0001
697 HEART RATE INCREASED 11 0.0001
698 PERIPHERAL SWELLING 17 0.0001
699 DRUG EFFECT INCOMPLETE 4 0.0001
700 HEADACHE 69 0.0001
701 GAIT DISTURBANCE 21 0.0001
702 EXOSTOSIS 1 0.0001
703 DIVERTICULITIS 3 0.0001
704 MENTAL STATUS CHANGES 3 0.0001
705 EYE SWELLING 4 0.0001
706 PAIN 66 0.0001
707 RENAL DISORDER 5 0.0001
708 SWELLING 10 0.0001
709 FLANK PAIN 1 0.0001
710 PHOTOPHOBIA 2 0.0001
711 ARTERIOSCLEROSIS 1 0.0001
712 INTESTINAL OBSTRUCTION 4 0.0001
713 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
714 HYPOCALCAEMIA 2 0.0001
715 FRACTURE 2 0.0001
716 NEOPLASM MALIGNANT 7 0.0001
717 SLEEP APNOEA SYNDROME 2 0.0001
718 INCREASED APPETITE 2 0.0001
719 HYPERSOMNIA 3 0.0001
720 AFFECT LABILITY 1 0.0001
721 PRESCRIBED OVERDOSE 2 0.0001
722 DYSTONIA 2 0.0001
723 AUTOIMMUNE DISORDER 1 0.0001
724 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
725 ORAL HERPES 2 0.0001
726 BODY TEMPERATURE DECREASED 1 0.0001
727 DEVICE ISSUE 9 0.0001
728 DEVICE MALFUNCTION 7 0.0001
729 SOMNOLENCE 20 0.0001
730 FEEDING DISORDER 2 0.0001
731 DRY THROAT 1 0.0001
732 ANXIETY 28 0.0001
733 DISCOMFORT 6 0.0001
734 EAR DISCOMFORT 1 0.0001
735 TOOTH LOSS 2 0.0001
736 PULMONARY HYPERTENSION 2 0.0001
737 RESPIRATORY FAILURE 7 0.0001
738 POLLAKIURIA 4 0.0001
739 ABDOMINAL DISCOMFORT 16 0.0001
740 DYSPHAGIA 9 0.0001
741 HYPOTHYROIDISM 3 0.0001
742 CHILLS 11 0.0001
743 METABOLIC ACIDOSIS 3 0.0001
744 BREAST PAIN 1 0.0001
745 JOINT INJURY 2 0.0001
746 IMPAIRED WORK ABILITY 2 0.0001
747 BODY HEIGHT DECREASED 1 0.0001
748 LIVER FUNCTION TEST INCREASED 2 0.0001
749 HYPOACUSIS 4 0.0001
750 POOR QUALITY SLEEP 2 0.0001
751 DECREASED ACTIVITY 1 0.0001
752 FAECES DISCOLOURED 2 0.0001
753 BACK INJURY 1 0.0001
754 PRODUCT DISPENSING ERROR 2 0.0001
755 PRODUCT PRESCRIBING ISSUE 2 0.0001
756 INJECTION SITE SWELLING 7 0.0001
757 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
758 ASPIRATION 1 0.0001
759 BLOOD GLUCOSE FLUCTUATION 1 0.0001
760 EYE DISORDER 3 0.0001
761 STAPHYLOCOCCAL INFECTION 3 0.0001
762 APPLICATION SITE PAIN 2 0.0001
763 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
764 INSOMNIA 24 0.0001
765 STEVENS-JOHNSON SYNDROME 2 0.0001
766 SKIN DISORDER 3 0.0001
767 URINARY RETENTION 3 0.0001
768 RASH MACULO-PAPULAR 2 0.0001
769 RASH PAPULAR 2 0.0001
770 BLISTER 5 0.0001
771 PARAESTHESIA 14 0.0001
772 BLOOD CALCIUM DECREASED 1 0.0001
773 ANGER 3 0.0001
774 HEPATIC ENZYME INCREASED 6 0.0001
775 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
776 HAEMATURIA 3 0.0001
777 RASH 38 0.0001
778 TINNITUS 4 0.0001
779 HAEMORRHAGE 9 0.0001
780 ELECTROLYTE IMBALANCE 1 0.0001
781 HEART RATE DECREASED 3 0.0001
782 HOSPITALISATION 13 0.0001
783 ATAXIA 1 0.0001
784 BACTERAEMIA 1 0.0001
785 CATARACT 5 0.0001
786 CHOLECYSTITIS 1 0.0001
787 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
788 ACCIDENT 1 0.0001
789 HEPATIC CANCER 2 0.0001
790 CRYING 3 0.0001
791 BURSITIS 1 0.0001
792 ADRENAL INSUFFICIENCY 1 0.0001
793 MYALGIA 14 0.0001
794 HYPERGLYCAEMIA 3 0.0001
795 UNDERDOSE 6 0.0001
796 MALAISE 36 0.0001
797 INJECTION SITE URTICARIA 2 0.0001
798 DYSURIA 3 0.0001
799 CARDIOMEGALY 1 0.0001
800 CYST 1 0.0001
801 VISION BLURRED 11 0.0001
802 DEATH 69 0.0001
803 BLOOD GLUCOSE INCREASED 15 0.0001
804 DERMATITIS ALLERGIC 1 0.0001
805 UNEVALUABLE EVENT 6 0.0001
806 BRAIN OEDEMA 1 0.0001
807 ABDOMINAL PAIN LOWER 2 0.0001
808 CARDIOVASCULAR DISORDER 2 0.0001
809 TREMOR 13 0.0001
810 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
811 ABDOMINAL PAIN UPPER 16 0.0001
812 HYPERHIDROSIS 10 0.0001
813 HAEMATOMA 2 0.0001
814 EXPOSURE VIA SKIN CONTACT 2 0.0001
815 SWELLING FACE 5 0.0001
816 PRODUCT DOSE OMISSION 5 0.0001
817 NERVOUSNESS 4 0.0001
818 SEDATION 2 0.0001
819 MUSCULOSKELETAL PAIN 4 0.0001
820 ARTHRITIS 6 0.0001
821 BEDRIDDEN 1 0.0001
822 EYE HAEMORRHAGE 1 0.0001
823 DRY SKIN 10 0.0001
824 CARDIAC FAILURE 6 0.0001
825 FEAR 2 0.0001
826 DRUG EFFECT DECREASED 4 0.0001
827 OEDEMA 4 0.0001
828 PULMONARY EMBOLISM 7 0.0001
829 CORONARY ARTERY OCCLUSION 1 0.0001
830 SKIN LESION 2 0.0001
831 INFLUENZA LIKE ILLNESS 6 0.0001
832 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
833 MEMORY IMPAIRMENT 10 0.0001
834 APPLICATION SITE RASH 1 0.0001
835 INJECTION SITE REACTION 5 0.0001
836 RESPIRATORY ARREST 2 0.0001
837 RESPIRATORY DISTRESS 2 0.0001
838 CONDITION AGGRAVATED 22 0.0001
839 COORDINATION ABNORMAL 1 0.0001
840 APHONIA 1 0.0001
841 RENAL IMPAIRMENT 6 0.0001
842 TARDIVE DYSKINESIA 2 0.0001
843 SLEEP DISORDER 5 0.0001
844 HYPERTENSION 15 0.0001
845 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
846 BALANCE DISORDER 6 0.0001
847 MENTAL DISORDER 3 0.0001
848 FLUID OVERLOAD 1 0.0001
849 NEEDLE ISSUE 2 0.0001
850 DYSSTASIA 2 0.0001
851 ERYTHEMA 14 0.0001
852 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
853 ACUTE MYOCARDIAL INFARCTION 2 0.0001
854 ANGIOEDEMA 3 0.0001
855 LIVER DISORDER 3 0.0001
856 URINARY INCONTINENCE 2 0.0001
857 RENAL INJURY 2 0.0001
858 DYSGEUSIA 5 0.0001
859 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
860 BONE LOSS 1 0.0001
861 INCORRECT DOSE ADMINISTERED 15 0.0001
862 VERTIGO 4 0.0001
863 SKIN IRRITATION 3 0.0001
864 MUSCLE SPASMS 12 0.0001
865 SKIN DISCOLOURATION 3 0.0001
866 DELUSION 1 0.0001
867 COGNITIVE DISORDER 3 0.0001
868 NERVOUS SYSTEM DISORDER 2 0.0001
869 DRUG-INDUCED LIVER INJURY 2 0.0001
870 RASH ERYTHEMATOUS 3 0.0001
871 ABSCESS 1 0.0001
872 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
873 LOSS OF CONSCIOUSNESS 8 0.0001
874 THROMBOSIS 5 0.0001
875 CONFUSIONAL STATE 10 0.0001
876 DEPRESSION 14 0.0001
877 AMNESIA 4 0.0001
878 CHOLELITHIASIS 2 0.0001
879 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
880 RENAL FAILURE 8 0.0001
881 DRY EYE 3 0.0001
882 COAGULOPATHY 1 0.0001
883 FACE OEDEMA 1 0.0001
884 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
885 DEVICE USE ERROR 2 0.0001
886 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
887 SPEECH DISORDER 3 0.0001
888 DEVICE USE ISSUE 1 0.0001
889 AMENORRHOEA 1 0.0001
890 DEPRESSED MOOD 3 0.0001
891 INJECTION SITE ERYTHEMA 7 0.0001
892 GALLBLADDER DISORDER 1 0.0001
893 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
894 BONE DISORDER 1 0.0001
895 TREATMENT NONCOMPLIANCE 3 0.0001
896 RESTLESSNESS 2 0.0001
897 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
898 INJECTION SITE MASS 2 0.0001
899 ARTHROPATHY 3 0.0001
900 BREAST CANCER 5 0.0001
901 HYPOAESTHESIA 8 0.0001
902 TOXICITY TO VARIOUS AGENTS 9 0.0001
903 DYSARTHRIA 2 0.0001
904 CEREBROVASCULAR ACCIDENT 9 0.0001
905 HOT FLUSH 4 0.0001
906 MUSCULAR WEAKNESS 6 0.0001
907 BLOOD URINE PRESENT 1 0.0001
908 FEELING JITTERY 1 0.0001
909 DIABETES MELLITUS 4 0.0001
910 CHOLESTASIS 1 0.0001
911 DRUG INTOLERANCE 5 0.0001
912 DISABILITY 1 0.0001
913 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
914 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
915 EMOTIONAL DISTRESS 6 0.0000
916 THERAPEUTIC RESPONSE DECREASED 3 0.0000
917 LUNG NEOPLASM MALIGNANT 2 0.0000
918 OSTEOPOROSIS 2 0.0000
919 VISUAL IMPAIRMENT 6 0.0000
920 TREATMENT FAILURE 4 0.0000
921 RECTAL HAEMORRHAGE 2 0.0000
922 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
923 VAGINAL HAEMORRHAGE 2 0.0000
924 DRUG WITHDRAWAL SYNDROME 4 0.0000
925 INJECTION SITE PRURITUS 3 0.0000
926 PULMONARY OEDEMA 2 0.0000
927 APPLICATION SITE PRURITUS 1 0.0000
928 DRUG INEFFECTIVE 58 0.0000
929 CARDIAC DISORDER 4 0.0000
930 INJURY 3 0.0000
931 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
932 OCULAR HYPERAEMIA 2 0.0000
933 BLOOD GLUCOSE DECREASED 2 0.0000
934 FIBROMYALGIA 1 0.0000
935 ENCEPHALOPATHY 1 0.0000
936 AGGRESSION 2 0.0000
937 HALLUCINATION 3 0.0000
938 ACNE 3 0.0000
939 GASTRIC CANCER 1 0.0000
940 INFLAMMATION 2 0.0000
941 DIPLOPIA 1 0.0000
942 DEAFNESS 1 0.0000
943 CARDIAC FAILURE CONGESTIVE 3 0.0000
944 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
945 ABNORMAL DREAMS 1 0.0000
946 DEMENTIA 1 0.0000
947 ANGINA PECTORIS 1 0.0000
948 EYE IRRITATION 2 0.0000
949 PRODUCT SUBSTITUTION ISSUE 2 0.0000
950 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
951 INTENTIONAL PRODUCT MISUSE 3 0.0000
952 IRRITABILITY 2 0.0000
953 NO ADVERSE EVENT 6 0.0000
954 APHASIA 1 0.0000
955 ILL-DEFINED DISORDER 2 0.0000
956 EPILEPSY 1 0.0000
957 ADVERSE EVENT 3 0.0000
958 BONE DENSITY DECREASED 1 0.0000
959 ATRIAL FIBRILLATION 3 0.0000
960 DEEP VEIN THROMBOSIS 2 0.0000
961 DEVICE DIFFICULT TO USE 2 0.0000
962 MYOCARDIAL INFARCTION 5 0.0000
963 CEREBRAL HAEMORRHAGE 1 0.0000
964 OVERDOSE 6 0.0000
965 AGITATION 2 0.0000
966 INJECTION SITE PAIN 8 0.0000
967 ABNORMAL BEHAVIOUR 1 0.0000
968 INJECTION SITE HAEMORRHAGE 2 0.0000
969 ABORTION SPONTANEOUS 1 0.0000
970 JOINT SWELLING 3 0.0000
971 EXTRA DOSE ADMINISTERED 1 0.0000
972 DYSKINESIA 1 0.0000
973 BLINDNESS 1 0.0000
974 CARDIAC ARREST 2 0.0000
975 CARDIO-RESPIRATORY ARREST 1 0.0000
976 SKIN EXFOLIATION 2 0.0000
977 DEVICE LEAKAGE 1 0.0000
978 PRODUCT STORAGE ERROR 2 0.0000
979 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
980 COLITIS ULCERATIVE 1 0.0000
981 ADVERSE DRUG REACTION 2 0.0000
982 SUICIDAL IDEATION 2 0.0000
983 BLOOD CHOLESTEROL INCREASED 1 0.0000
984 ARRHYTHMIA 1 0.0000
985 ECZEMA 1 0.0000
986 DERMATITIS ATOPIC 1 0.0000
987 DRUG INTERACTION 3 0.0000
988 DRUG DEPENDENCE 3 0.0000
989 DRUG DOSE OMISSION 3 0.0000
990 ANAPHYLACTIC REACTION 1 0.0000
991 EYE PAIN 1 0.0000
992 CONVULSION 1 0.0000
993 DRUG ABUSE 1 0.0000